Updated Jun. 13, 2011 at 3:38 p.m.

Premium Lock GSK wins FDA approval for epilepsy drug

Published: 2011-06-13 15:21:00
Updated: 2011-06-13 15:38:47

GSK GSK

More than 2 million people in the U.S. have been diagnosed with epilepsy or suffered from an unprovoked seizure, according to the National Institute of Neurological Disorders and Stroke. Glaxo and Valeant estimate that a third of patients can't control seizures with current epilepsy medicines, leading to disability and an unsatisfactory quality of life....

Read More
Read More

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll